Pharmacological and expression profile of the prostaglandin I2 receptor in the rat craniovascular system

Abstract Activation of the trigeminal nerve terminals around cerebral and meningeal arteries is thought to be an important patho-mechanism in migraine. Vasodilatation of the cranial arteries may also play a role in increasing nociception. Prostaglandin I 2 (PGI 2 ) is capable of inducing a headache in healthy volunteers, a response that is likely to be mediated by the prostaglandin I 2 receptor (IP). This study investigates the functional and molecular characteristics of the IP receptor in the rat craniovascular system. In the closed cranial window model, iloprost, an IP receptor agonist, dilated the rat middle meningeal artery (MMA) (E max  = 170% ± 16%; pED 50  = 6.5 ± 0.2) but not the rat cerebral artery (CA) in vivo . The specific antagonist of the IP receptor, CAY10441, significantly blocked the iloprost-induced response dose-dependently, with the highest dose attenuating iloprost (1 μg kg − 1 ) induced dilatations by 70% ( p 2 -induced vasodilatory response, thus suggesting no interaction with EP 2 and EP 4 receptors. IP receptor mRNA transcripts and protein were present in meningeal as well as in cerebral rat vasculature, and localized the IP receptor protein to the smooth vasculature of the cranial arteries (MMA, MCA and basilar artery). Together, these results demonstrate that the IP receptor mediates the dilatory effect of PGI 2 in the cranial vasculature in rats. Antagonism of this receptor might be of therapeutic relevance in acute migraine treatment.